IBM explores various tools of nanotechnology to employ them in biomedical application for monitoring of pathogens (harmful viruses and bacteria) and human diseases by detecting a trace amount of biomolecules.

IBM applies concepts and techniques from material science, chemistry, physics, biology and biomedical engineering to address clinical questions in cancer, stem cell, pathology, and public health research.